General Gynecology
The USPSTF maintains the recommendation to screen for chlamydia and gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.
15 Sep, 2021 | 08:57h | UTCEditorial: Screening for Chlamydia and Gonorrhea – JAMA
Evidence Report : Screening for Chlamydial and Gonococcal Infections: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
Author Interview: USPSTF Recommendation: Screening for Chlamydia and Gonorrhea
JAMA Patient Page: Screening for Chlamydia and Gonorrhea
Review | Recommendations and Nutritional Considerations for Female Athletes: Health and Performance.
15 Sep, 2021 | 08:49h | UTC
Guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery.
26 Aug, 2021 | 08:32h | UTC
Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging.
25 Aug, 2021 | 08:59h | UTCRelated:
2 Case Series and Guidance| Lymphadenopathy in COVID-19 Vaccine Recipients
COVID-19 vaccine-linked adenopathies could mimic breast malignancies
ACOG Guideline: Osteoporosis prevention, screening, and diagnosis.
22 Aug, 2021 | 23:08h | UTC
Cohort study: Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers.
20 Aug, 2021 | 08:39h | UTC
Commentary on Twitter
For #BRCA1 mutation carriers, longer duration of oral contraceptive use (>10 yr) is associated with a greater reduction in #OvarianCancer risk, and the protection is long term. https://t.co/HrrutgaYKX
— Anna Chichura, MD (@AnnaChichuraMD) July 3, 2021
RCT: Effect of sacrospinous hysteropexy with graft vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse.
13 Aug, 2021 | 08:52h | UTCEffect of sacrospinous hysteropexy with graft vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: 5-year results of a randomized clinical trial – American Journal of Obstetrics & Gynecology (link to abstract – $ for full-text)
Commentary on Twitter (video summary)
https://t.co/DvGgwjug34#SUPeRTrial#PFDNresearch @AJOG_thegray pic.twitter.com/PDDr6NvGNV
— Pelvic Floor Disorders Network (PFDN) (@PFDNresearch) April 9, 2021
ACOG Guideline: Access to postabortion contraception.
10 Aug, 2021 | 08:57h | UTCAccess to Postabortion Contraception: ACOG Committee Opinion, Number 833 – Obstetrics & Gynecology
Review: Diseases and complications of the puerperium.
10 Aug, 2021 | 08:46h | UTCDiseases and Complications of the Puerperium – Deutsches Ärzteblatt International
ASCO Resource-Stratified Guideline: Assessment of adult women with ovarian masses and treatment of epithelial ovarian cancer.
8 Aug, 2021 | 23:38h | UTCCommentary: ASCO Publishes Resource-Stratified Guideline on Assessment and Treatment of Ovarian Cancer – The ASCO Post
Mammographic features are associated with cardiometabolic disease risk and mortality.
6 Aug, 2021 | 09:04h | UTC
RCT: Effect of an active vs. expectant management strategy on successful resolution of pregnancy among patients with a persisting pregnancy of unknown location.
4 Aug, 2021 | 09:00h | UTCEffect of an Active vs Expectant Management Strategy on Successful Resolution of Pregnancy Among Patients With a Persisting Pregnancy of Unknown Location: The ACT or NOT Randomized Clinical Trial – JAMA (free for a limited period)
Commentary: Active Management More Effective for Pregnancy of Unknown Location – MedPage Today (free registration required)
CDC releases new guidelines for the treatment of sexually transmitted infections.
23 Jul, 2021 | 10:41h | UTCTable of Contents: Sexually Transmitted Infections Treatment Guidelines, 2021
Related (just released): WHO Guidelines for the management of symptomatic sexually transmitted infections.
Commentary on Twitter (thread – click for more)
Here's my greatest hits from today’s new @CDCSTD #STI Treatment Guidelines: a 🧵
1)#STI guidelines instead of #STD!
2)Expedited Partner Therapy: not just for “heterosexuals” 👏
3)#HepatitisC: screen all pregnant people
4)Rectal/throat GC/CT: consider for non-MSM like teens 👏 pic.twitter.com/gfEhrWpMKA— Ina Park (@InaParkMD) July 22, 2021
WHO Guidelines for the management of symptomatic sexually transmitted infections.
22 Jul, 2021 | 10:54h | UTCNews release: Launch WHO guidelines for the management of symptomatic sexually transmitted infection – World Health Organization
Commentary on Twitter
Great see @WHO new guidelines #STIs https://t.co/SgkCtcMDbv BUT hope last edition w syndromic management. Must deliver diagnostic capacity LMICs pic.twitter.com/B7ugeUpIRG
— Michael Marks (@dr_michaelmarks) July 17, 2021
Review: Diagnosis, evaluation, and treatment of adenomyosis.
14 Jul, 2021 | 11:01h | UTCDiagnosis, Evaluation, and Treatment of Adenomyosis – JAMA (free for a limited period)
Podcast | Heavy menstrual bleeding, anticoagulation & coagulopathy in menstruating patients.
9 Jul, 2021 | 09:56h | UTC
Clinical guidelines for female lower urinary tract symptoms.
8 Jul, 2021 | 08:44h | UTCClinical Guidelines for Female Lower Urinary Tract Symptoms – International Journal of Urology
New WHO recommendations for screening to prevent cervical cancer – the new guideline recommends an HPV DNA based test every 5 years as the preferred method, rather than visual inspection with acetic acid (VIA) or cytology (Pap smear).
7 Jul, 2021 | 08:51h | UTCNews release: New recommendations for screening and treatment to prevent cervical cancer – World Health Organization
Commentary on Twitter (thread – click for more)
🆕 recommendations for screening and treatment to prevent #CervicalCancer will help countries take the next step towards elimination. Cervical #cancer is the 4th most common cancer among women worldwide 🌎🌍🌏
👉 https://t.co/2vfxqa9FMB pic.twitter.com/zC0h20nAce
— World Health Organization (WHO) (@WHO) July 6, 2021
Putting people first in managing their health: new WHO guideline on self-care interventions – “Whether it’s for their experience of pregnancy and childbirth; managing fertility intentions, preventing sexually transmitted infections; enjoying better sexual health of themselves or their partner, or self-monitoring their blood pressure, access to quality self-care interventions can help meet people’s many health needs and rights”.
28 Jun, 2021 | 09:40h | UTCNews release: Putting people first in managing their health: new WHO guideline on self-care interventions – World Health Organization
See guidance: WHO consolidated guideline on self-care interventions for health
Commentary on Twitter (thread – click for more)
https://twitter.com/WHO/status/1408350517428953091
Guideline | Perimenopause and Postmenopause – Diagnosis and Interventions.
28 Jun, 2021 | 09:32h | UTC
Review: chronic pelvic pain in women.
17 Jun, 2021 | 09:36h | UTCChronic Pelvic Pain in Women: A Review – JAMA (free for a limited period)
Audio clinical review: Diagnosis and Clinical Care of Women With Chronic Pelvic Pain
Pessaries for pelvic organ prolapse – looking at the Cochrane evidence.
24 May, 2021 | 08:17h | UTCPessaries for pelvic organ prolapse – looking at the Cochrane evidence – Evidently Cochrane
Original Review: Pessaries (mechanical devices) for managing pelvic organ prolapse in women – Cochrane Library
#ACC21 – The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 – “The Lancet women and cardiovascular disease Commission outlines 10 ambitious recommendations to improve health outcomes for millions of women”.
18 May, 2021 | 07:32h | UTCHomepage: The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 – The Lancet (free registration required)
Infographic: Women and cardiovascular disease
Video: The Lancet women and cardiovascular disease Commission
News release: Experts call for urgent action to reduce global burden of cardiovascular disease in women by 2030 – The Lancet
Commentary on Twitter (thread – click for more)
Cardiovascular disease is responsible for 35% of deaths in women yearly—yet remains:
❣️Understudied
❣️Under-recognised
❣️Underdiagnosed
❣️UndertreatedNEW @TheLancet Commission outlines 10 recommendations to improve health outcomes for millions of women: https://t.co/DDB97FFunC pic.twitter.com/WjV3aqqLV9
— The Lancet (@TheLancet) May 17, 2021
Large trial with over 200.000 patients finds ovarian cancer screening does not reduce deaths.
14 May, 2021 | 08:32h | UTCCommentaries: Screening for ovarian cancer did not reduce early deaths – Imperial College London AND Annual screening for ovarian cancer does not save lives, study finds – The Guardian
RCT: Community pharmacies provision of a progestogen-only pill + invitation to a sexual and reproductive health clinic as a bridging contraception intervention for women receiving emergency contraception is associated with increased subsequent use of long-term effective contraception.
10 May, 2021 | 00:45h | UTC